Jeffrey Drebin

Jeffrey A. Drebin is an American physician-scientist and surgical oncologist, Chair of Surgery at Memorial Sloan Kettering Cancer Center, whose doctoral research with Mark Greene and Robert Weinberg produced monoclonal antibodies against the HER2/neu oncogene, foundational work toward targeted therapies such as trastuzumab (Herceptin). He is listed among Jewish figures in biomedical science, though a Jewish background is not otherwise documented in mainstream biographical sources. He specializes in pancreatic and hepatobiliary cancer surgery.